Skip to main content
OpenTrials

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,146 public trials 2,034 recruiting studies
Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Recruiting

Buprenorphine Implementation at Syringe Service Programs to Reduce Overdoses

NCT07631598

Conditions
Chemically-Induced Disorders, Hemic and Lymphatic Diseases, Immune System Diseases, +15 more
Locations
  • Community Health Project Los Angeles (CHPLA) Los Angeles, California, United States
  • HIPS Washington D.C., District of Columbia, United States
  • CARPBR/Be Safe Syringe Program Baton Rouge, Louisiana, United States
  • Harm Reduction Sisters Duluth, Minnesota, United States
View Trial Details
Recruiting

A Study of Obecabtagene Autoleucel in People With B-cell Acute Lymphoblastic Leukemia

NCT07400029

Conditions
Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations
  • Stanford University (Data Collection AND Specimen Analysis) Stanford, California, United States
  • Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
View Trial Details
Recruiting

A Phase-3-trial of Acalabrutinib, Obinutuzumab & Venetoclax Compared to Obinutuzumab and Venetoclax in Previously Untreated Patients With High Risk CLL

NCT05197192

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
Locations
  • Helios Klinikum Bad Saarow Bad Saarow, Germany
  • DRK Kliniken Berlin Köpenick Berlin, Germany
  • Ev. Diakoniekrankenhaus Bremen, Germany
  • Universitätsklinik Köln Cologne, Germany
View all 30 locations
View Trial Details
Recruiting

Gustabor Phase 2 - Treating Taste Changes During Cancer Therapy: A Randomized Study Evaluating an AI- Based Nutrition Intervention

NCT07649681

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Digestive System Diseases, +42 more
Locations
  • Universitätsklinikum Augsburg Augsburg, Bavaria, Germany
  • Universitätsklinikum Erlangen Erlangen, Bavaria, Germany
  • LMU Klinikum Krebszentrum - CCC MünchenLMU - Comprehensive Cancer Center München, Bavaria, Germany
  • Klinikum der Technischen Universität München (TUM Klinikum) München, Bavaria, Germany
View Trial Details
Recruiting

A Clinical Study of MK-1045 (CN201) in People With Precursor B-cell Acute Lymphoblastic Leukemia (MK-1045-002)

NCT05579132

Conditions
Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations
  • The Second Affiliated Hospital of Third Military Medical University ( Site 0008) Chongqing, Chongqing Municipality, China
  • Southern Medical University Nanfang Hospital ( Site 0004) Guangzhou, Guangdong, China
  • The Second Hospital of Hebei Medical University ( Site 0003) Shijiazhuang, Hebei, China
  • The First Hospital of Harbin ( Site 0005) Harbin, Heilongjiang, China
View Trial Details

Related conditions